Strength in Genes: Gene Therapy's Potential for Treating Muscular Dystrophy #musculardystrophy

Gene Therapy #sciencefather #molecularbiologist #biologist #GeneTherapy #LGMDR9Подробнее

Gene Therapy #sciencefather #molecularbiologist #biologist #GeneTherapy #LGMDR9

Losmapimod as a potential treatment for facioscapulohumeral muscular dystrophy (FSHD)Подробнее

Losmapimod as a potential treatment for facioscapulohumeral muscular dystrophy (FSHD)

CureDuchenne and Avidity Biosciences: EXPLORE44TMПодробнее

CureDuchenne and Avidity Biosciences: EXPLORE44TM

Potential treatment may help patients with muscular dystrophyПодробнее

Potential treatment may help patients with muscular dystrophy

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth, Trends, Key Players, and Outlook 2024Подробнее

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth, Trends, Key Players, and Outlook 2024

Strength in Genes: Gene Therapy's Potential for Treating Muscular Dystrophy #musculardystrophyПодробнее

Strength in Genes: Gene Therapy's Potential for Treating Muscular Dystrophy #musculardystrophy

The Croonian Lecture 2019: from diagnosis to therapy in Duchenne muscular dystrophyПодробнее

The Croonian Lecture 2019: from diagnosis to therapy in Duchenne muscular dystrophy

PPMD 2019 Conference - CRISPR: Future Strategies in Gene TherapyПодробнее

PPMD 2019 Conference - CRISPR: Future Strategies in Gene Therapy

[Webinar] Is Myostatin Still a Potential Therapeutic Target? - October 2018Подробнее

[Webinar] Is Myostatin Still a Potential Therapeutic Target? - October 2018

Fulcrum Phase 2b trial resultsПодробнее

Fulcrum Phase 2b trial results

FSHD Society webinar on CRISPR and FSH muscular dystrophy with Charis HimedaПодробнее

FSHD Society webinar on CRISPR and FSH muscular dystrophy with Charis Himeda